Conventional orthopedics is excellent at imaging, immobilizing, and replacing what's worn out. Regenerative medicine asks a different question: can the underlying biology be reactivated? Here's what the science currently supports — and what we use at Innovita Clinic to put it to work.
By Jed Ryan, Founder and CEO · Reviewed by Adas Darinskas, PhD, Chief Science Officer · Published · Last reviewed
Musculoskeletal conditions are the slow-burn problems of the structural body — joints, cartilage, tendons, ligaments, intervertebral discs, and the connective tissue that ties them together. Most don't arrive overnight. They build over years of mechanical load, micro-injury, and the gradual decline of the cellular machinery that's supposed to be repairing all of it in the background.
For the patients we work with, the cluster includes:
These conditions look structurally different on imaging, but they share a common biological fingerprint underneath. That shared biology is where regenerative medicine has something to offer — not as a replacement for orthopedic care, but as a different angle of approach.
Whether the entry point is a torn meniscus, a worn-out hip, or a tendon that won't quit complaining, the same four systems tend to be in trouble. Targeting them is the basis of every regenerative protocol.
Anti-inflammatories quiet the first system temporarily. Joint replacements solve the structural endpoint when the second has gone too far. Neither addresses systems three or four. Regenerative medicine targets all four at once.
There's no magic step here. The treatments we coordinate work through well-characterized cellular mechanisms — the same mechanisms the body uses when it repairs young, well-perfused tissue successfully on its own.
None of these mechanisms are speculative. They're how repair already works when it's working. Regenerative medicine reintroduces those signals to tissue that's lost the ability to generate them on its own.
The specific protocol Dr. Adas Darinskas designs for any given patient depends on tissue, severity, and history. But the building blocks below are the ones most often deployed for musculoskeletal cases — and each is chosen for a reason.
An advanced class of mesenchymal stem cells with a stress-enduring property: they survive the inflammatory, hypoxic, low-pH environment of damaged joint and tendon tissue, where conventional MSCs often die before they can work. They home to injury, modulate inflammation, and contribute to matrix repair through both paracrine signaling and direct differentiation.
Learn moreStem-cell-derived nanoparticles that carry the regenerative messaging without the cells themselves. Smaller than MSCs, they diffuse through dense connective tissue more readily, reaching areas hard to inject directly. Often layered with cellular therapy or used alone in chronic tendinopathy and stubborn soft-tissue cases.
Learn moreTwo of the best-characterized regenerative peptides for musculoskeletal indications. BPC-157 supports tendon, ligament, and gut healing through angiogenesis and growth-factor expression. TB-500 (thymosin beta-4) accelerates cell migration and tissue repair. Typically run as a defined-duration cycle following the in-clinic cellular work.
Learn moreHigh-dose vitamin C, glutathione, NAD+, and amino-acid infusions support the metabolic load of active regeneration. Not a substitute for the cellular work — but the regenerative cells and peptides perform measurably better in a well-resourced internal environment.
Learn moreFor most musculoskeletal cases the protocol layers these — a localized MSC injection paired with systemic IV cellular delivery, exosomes added on the same day, peptide cycles continuing at home, and metabolic IVs supporting the days that matter most. None of it is generic. It's designed to your case.
Strong Craft Regen maintains a continuously updated repository of peer-reviewed research on regenerative medicine — the studies, mechanisms, and ongoing investigations that inform every protocol we coordinate.
Explore the research →